BCMU
JAZZ icon

BlueCrest Capital Management (UK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1M Buy
+6,250
New +$961K 0.04% 335
2014
Q2 		– Sell
-10,000
Closed -$1.39M – 655
2014
Q1 		$1.39M Buy
+10,000
New +$1.51M 0.08% 253

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlueCrest Capital Management (UK)'s JAZZ Position: Q3 2014 in Review

BlueCrest Capital Management (UK) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2014: 6,250 shares worth $1M. The stake represents 0.04% of the portfolio and ranks #335 among its holdings. This is a return to the name: BlueCrest Capital Management (UK) previously reported a position in JAZZ as recently as Q1 2014.

BlueCrest Capital Management (UK) first reported a position in JAZZ in Q1 2014 and has held it in 2 quarters since. The position peaked at $1.39M in Q1 2014. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

  • BlueCrest Capital Management (UK) held 6,250 shares of Jazz Pharmaceuticals worth $1M as of Q3 2014.
  • Jazz Pharmaceuticals was a new BlueCrest Capital Management (UK) position in Q3 2014.
  • Jazz Pharmaceuticals made up 0.04% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #335 holding.
  • BlueCrest Capital Management (UK) first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 2 quarters since.
  • BlueCrest Capital Management (UK)'s Jazz Pharmaceuticals position peaked at $1.39M in Q1 2014.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.